Test Price
2,800 AEDโ Home Collection Available
MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test in UAE
Executive Summary & Core Metrics
Executive Summary
This advanced genetic test provides complete sequencing of the MT-ND1 gene using next-generation sequencing (NGS) to detect mutations causing mitochondrial complex I deficiency. Certified by DHA and aligned with international standards, it delivers precise diagnosis for neurological and metabolic conditions in adults and children. Home collection is available alongside post-test clinical support.
- โAccuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS pipeline with Sanger validation.
- โPremium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- โClinical Guidance: Complimentary telephonic post-test clinical correlation session with a DHA-licensed molecular geneticist.
- โInsurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The MT-ND1 gene test employs deep next-generation sequencing to identify pathogenic variants in the mitochondrial gene encoding subunit 1 of NADH dehydrogenase. It is the gold-standard investigation for suspected mitochondrial complex I deficiency, a condition linked to Leigh syndrome, mitochondrial encephalomyopathy, and multisystem energy failure. The methodology captures heteroplasmy down to 1% and includes Sanger confirmation for all clinically significant variants.
| Feature | Our MT-ND1 NGS Test | Closest Alternative (Targeted Panel) |
|---|---|---|
| Method | Full gene NGS + Sanger confirmation | Pre-defined amplicons; may miss deep intronic or novel variants |
| Heteroplasmy Detection | Down to 1% heteroplasmy | Typically 5โ10%, missing low-level mosaicism |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Clinical Support | Post-test genetic counselling included | Report only; additional consultation needed |
| UAE Compliance | DHA Registered, ISO 9001:2015 | May not hold UAE-specific certification |
Physician Insight & Safety Protocols
โA positive MTโND1 result defines the molecular diagnosis but does not replace a thorough clinical evaluation. Every variant must be interpreted alongside the patientโs neurological, cardiac, and metabolic phenotype. Never stop any prescribed medication or supplement regimen without direct consultation with your treating physician โ mitochondrial patients often depend on precise metabolic support that must not be interrupted.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisories
- Do not self-collect if the patient has a bleeding disorder, severe needle phobia, or has experienced a vasovagal episode in the last 6 months. Home collection personnel are trained to recognize these risks and will escalate.
- Emergency red flags: Seek immediate medical attention if the patient exhibits acute metabolic decompensation โ sudden lethargy, vomiting, seizures, or loss of consciousness โ before or during the testing process. This test is not for acute crisis management.
- Do not discontinue prescribed mitochondrial cofactors (e.g., Coenzyme Q10, riboflavin, Lโcarnitine) in preparation for the test. Interruption may precipitate metabolic instability.
Exclusion Criteria
- This test is not recommended for asymptomatic minors without informed consent from a legal guardian, as mandated by UAE federal regulations. Testing in children requires a referral from a pediatric neurologist or medical geneticist.
- Patients with acute metabolic crisis or on mechanical ventilation should not undergo blood draw for this test until stabilized.
Patient FAQ & Clinical Guidance
1. What does the MT-ND1 gene test detect, and how does NGS improve accuracy?
This test sequences the entire MT-ND1 mitochondrial gene to identify disease-causing mutations responsible for complex I deficiency, including low-level heteroplasmy that conventional methods miss. Next-generation sequencing reads every nucleotide multiple times, enabling detection of variants present in as few as 1% of mitochondrial DNA copies. This is critical for mitochondrial disorders where tissue-specific heteroplasmy can mask the diagnosis. The methodology follows current best-practice guidelines with Sanger cross-validation.
2. Can an FTA card be used for sample collection from infants at home?
Yes, a single drop of blood on an FTA card is acceptable for collection from infants and children at home without the need for venipuncture, provided parental consent is obtained. FTA technology enables painless collection via heel or finger prick and ensures DNA stability during transport in the ISO-certified cold chain. A pediatric geneticist referral is required for consent forms.
3. How do I interpret a negative result when symptoms are highly suggestive?
A negative NGS result does not exclude mitochondrial disease; it may indicate variants in other genes, heteroplasmy below detection limit, or tissue-specific mutations not present in blood. In such cases, clinicians are advised to consider muscle biopsy or broader mitochondrial genome analysis. Our post-test tele-guidance reviews the complete clinical picture and may recommend follow-up testing (e.g., whole mitochondrial genome NGS) at no additional counselling cost.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic data is pseudonymized, encrypted, and stored in an ISO-certified biobank with controlled access.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Digital health records and telemedicine consultations meet strict security and interoperability standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Patient consent and safety protocols follow this law, ensuring informed decision-making and clinical accountability.
- DHA Facility License 1143: DNA Labs UAE operates under DHA Regulation, guaranteeing quality and reliability.
Clinical & Logistical Metadata
| Test Name | MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3โ5 mL EDTA) or FTA card (dried blood spot) |
| Methodology Used | Next-Generation Sequencing (full gene) with Sanger confirmation |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License #1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians